Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 14, 2024Alzheimer s Research & TherapyOpen Access

Proximity extension assay in cerebrospinal fluid identifies neurofilament light chain as biomarker of neurodegeneration in sporadic cerebral amyloid angiopathy

View Full Paper
Ask AI
Bookmark
Share

Authors

MVMarc VervuurtHKH. Bea KuiperijAKAnna M. de Kort

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Vervuurt et al. (2024) studied this question.

synapsesocial.com/papers/68e6a3bcb6db643587627565https://doi.org/10.1186/s13195-024-01473-0
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease2022 · 112 citations
  2. 2Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach1988 · 23,064 citations
  3. 3Understanding the Pathophysiology of Cerebral Amyloid Angiopathy2020 · 91 citations
  4. 4Neurofilament-light chain quantification by Simoa and Ella in plasma from patients with dementia: a comparative study2023 · 71 citations
  5. 5Neurodegenerative biomarkers outperform neuroinflammatory biomarkers in amyotrophic lateral sclerosis2023 · 15 citations